{
    "clinical_study": {
        "@rank": "16623", 
        "arm_group": {
            "arm_group_label": "Single arm", 
            "arm_group_type": "Other", 
            "description": "Single arm study study for use of Shang Ring device for male circumcision in children"
        }, 
        "brief_summary": {
            "textblock": "A proof of concept study to evaluate the feasibility of using the Shang Ring, a novel male\n      circumcision device across all childhood age groups namely infants (under 1), 1-5 age group,\n      6-12 age group and the 13-17 age group. The study will evaluate the safety, efficacy and\n      course of wound healing when using the Shang Ring technique across the four childhood age\n      groups."
        }, 
        "brief_title": "Use of Male Circumcision Device in All Four Childhood Groups in the African Population", 
        "completion_date": {
            "#text": "November 2013", 
            "@type": "Actual"
        }, 
        "condition": "Human Immunodeficiency Virus", 
        "condition_browse": {
            "mesh_term": [
                "Acquired Immunodeficiency Syndrome", 
                "HIV Infections", 
                "Immunologic Deficiency Syndromes"
            ]
        }, 
        "detailed_description": {
            "textblock": "A proof of concept study to evaluate the feasibility of using the Shang Ring, a novel male\n      circumcision device across all childhood age groups namely infants (under 1), 1-5 age group,\n      6-12 age group and the 13-17 age group. The study will evaluate efficacy, procedure time,\n      difficulties during surgery and post-operative events shall be assessed. To evaluate safety,\n      the investigators will clinically observe for adverse events during the course of healing.\n      The investigators will also evaluate to length of time taken for complete healing to be\n      achieved."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Must be accompanied by the parent or legally acceptable representative (LAR), who\n             freely consents   for participation of the child into the study;\n\n          -  Assent from participant 7 years of age and above who understand study procedure;\n\n          -  Aged between 1 month and 17 years(inclusive);\n\n          -  Body weight of more than 2.5 kgs and penile shaft more than 1 cm in length.\n\n          -  Must be in good general health;\n\n          -  Must be free of genital ulcerations or other visible signs of STI (on examination);\n\n          -  Parent or LAR and if possible the client must be able to understand study procedures\n             and requirements of study participation;\n\n          -  Parent or LAR must agree to return the client to the study site for the full schedule\n             of follow-up visits after his circumcision;\n\n          -  Parent or LAR must have a cell phone or access to a cell phone; and,\n\n          -  Parent or LAR must agree to provide the study staff with an address, phone number, or\n             other locator information while participating in the research study.\n\n        Exclusion Criteria:\n\n          -  Has a known allergy or sensitivity to lidocaine or other local anesthesia;\n\n          -  Takes a medication that would be a contraindication for elective surgery, such as an\n             anticoagulant or steroid;\n\n          -  Has known bleeding/clotting disorder (e.g. hemophilia);\n\n          -  Has  any congenital genitourinary abnormality;\n\n          -  Has an active genital infection, anatomic abnormality or other condition (e.g. severe\n             obesity, diabetes or sickle cell anemia), which in the opinion of the surgeon,\n             prevents the man from undergoing a circumcision as part of this study; or\n\n          -  Is currently participating in another biomedical research study."
            }, 
            "gender": "Male", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "17 Years", 
            "minimum_age": "1 Month"
        }, 
        "enrollment": {
            "#text": "80", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "June 25, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01891409", 
            "org_study_id": "GCC-0139-01", 
            "secondary_id": "GCC-0139"
        }, 
        "intervention": {
            "arm_group_label": "Single arm", 
            "intervention_name": "Male circumcision using the Shang Ring device", 
            "intervention_type": "Device", 
            "other_name": "Shang ring male circumcision device"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "HIV prevention", 
            "Male Circumcision", 
            "Children", 
            "Childhood", 
            "Shang Ring"
        ], 
        "lastchanged_date": "February 11, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Homa Bay", 
                    "country": "Kenya"
                }, 
                "name": "Homa Bay District Hospital"
            }
        }, 
        "location_countries": {
            "country": "Kenya"
        }, 
        "number_of_arms": "1", 
        "official_title": "Use of Male Circumcision Device in All Four Childhood Groups in the African Population", 
        "overall_official": {
            "affiliation": "EngenderHealth", 
            "last_name": "Quentin Awori, MBChB, CPI", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "Kenya: Ethical Review Committee", 
                "Kenya: Ministry of Health"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Documentation of adverse events based on clinical exam findings", 
            "measure": "To evaluate safety when using the Shang Ring technique across the 4 age groups ranging from infants to adolescents.", 
            "safety_issue": "Yes", 
            "time_frame": "42 days after circumcision"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01891409"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "To evaluate efficacy, procedure time, peri- and postoperative surgical complications, and problems with use of the device will be assessed.", 
                "measure": "To evaluate efficacy when using the Shang Ring technique across the 4 age groups ranging from infants to adolescents.", 
                "safety_issue": "Yes", 
                "time_frame": "42 days after circumcision"
            }, 
            {
                "description": "Evaluation of the course of healing and length of time required for complete healing will be based on clinical exam findings.", 
                "measure": "To evaluate the course of wound healing when using the Shang Ring technique across the 4 age groups ranging from infants to adolescents.", 
                "safety_issue": "Yes", 
                "time_frame": "42 days after circumcision"
            }, 
            {
                "description": "Clients and/or parents shall be interviewed on their experience with the Shang Ring during their participation in the study.", 
                "measure": "To determine the acceptability of the Shang Ring device by the participants (or their parents)", 
                "safety_issue": "No", 
                "time_frame": "42 days after circumcison"
            }, 
            {
                "description": "To evaluate the ease of use of the Shang Ring device, clinicians shall be interviewed on the difficulties they faced with using the device and their perception about use of the device relative to conventional surgical approaches", 
                "measure": "To evaluate the ease of use of the Shang Ring technique across the 4 age groups ranging from infants to adolescents", 
                "safety_issue": "No", 
                "time_frame": "42 days after circumcision"
            }
        ], 
        "source": "EngenderHealth", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Weill Medical College of Cornell University", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Kenya National AIDS & STI Control Programme", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Kenya Ministry of Health", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "EngenderHealth", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}